Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04869319
Other study ID # QI-A1C
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 13, 2020
Est. completion date March 28, 2024

Study information

Verified date April 2024
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Studying subjects with HbA1C tests >10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.


Recruitment information / eligibility

Status Completed
Enrollment 2403
Est. completion date March 28, 2024
Est. primary completion date March 28, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - MyChart active patients with HbA1C tests >10 and no follow-up test within 6 months and no appointments scheduled in the next 60 days from data run date Exclusion Criteria: - Patients with a scheduled appointment within 60 days from time algorithm is run; hospital encounters; non English or Spanish patients as indicated by primary language in Epic

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
MyChart message
Message subjects through MyChart to follow-up with their provider to schedule a follow up HbA1C test.

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of follow up A1C within 9 months after original A1C (allowing 3 months after email is sent) This outcome measures the rate at which participants complete an A1C test within 3 months of the message intervention being sent and 9 months of their original test. 2 years
See also
  Status Clinical Trial Phase
Completed NCT03816514 - Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range N/A
Completed NCT02722759 - Haemoglobin Measurement for Babies N/A
Completed NCT01529502 - Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting Phase 2
Terminated NCT00228995 - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia Phase 2
Terminated NCT00210795 - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia Phase 2
Recruiting NCT04189250 - Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol N/A
Completed NCT02876627 - Effect Aerobic Training on Women With Breast Cancer After Chemotherapy Phase 1
Completed NCT02655107 - Non-invasive Measurement of Hemoglobin in Infants and Neonates N/A
Terminated NCT00246597 - A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer Phase 3
Completed NCT05506748 - Association Between Preoperative HALP and Immediate Postoperative Outcomes